ES546974A0 - Un procedimiento de eliminacion del virus lav. - Google Patents

Un procedimiento de eliminacion del virus lav.

Info

Publication number
ES546974A0
ES546974A0 ES546974A ES546974A ES546974A0 ES 546974 A0 ES546974 A0 ES 546974A0 ES 546974 A ES546974 A ES 546974A ES 546974 A ES546974 A ES 546974A ES 546974 A0 ES546974 A0 ES 546974A0
Authority
ES
Spain
Prior art keywords
elimination
procedure
lav
virus lav
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES546974A
Other languages
English (en)
Other versions
ES8608884A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut Pasteur de Lille filed Critical Centre National de la Recherche Scientifique CNRS
Publication of ES546974A0 publication Critical patent/ES546974A0/es
Publication of ES8608884A1 publication Critical patent/ES8608884A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES546974A 1984-09-14 1985-09-13 Un procedimiento de eliminacion del virus lav. Expired ES8608884A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8414172A FR2570278B1 (fr) 1984-09-14 1984-09-14 Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise

Publications (2)

Publication Number Publication Date
ES546974A0 true ES546974A0 (es) 1986-09-01
ES8608884A1 ES8608884A1 (es) 1986-09-01

Family

ID=9307750

Family Applications (1)

Application Number Title Priority Date Filing Date
ES546974A Expired ES8608884A1 (es) 1984-09-14 1985-09-13 Un procedimiento de eliminacion del virus lav.

Country Status (8)

Country Link
EP (1) EP0176429B1 (es)
JP (2) JP2783403B2 (es)
AT (1) ATE58478T1 (es)
CA (1) CA1273304A (es)
DE (2) DE3583400D1 (es)
ES (1) ES8608884A1 (es)
FR (1) FR2570278B1 (es)
OA (1) OA08099A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2592893A1 (fr) * 1986-01-15 1987-07-17 Pasteur Institut Population de lymphocytes t4 specifiques du virus lav, leur procede d'obtention et leur application a la production de ce virus.
IL83687A (en) * 1987-08-30 1995-03-30 Yeda Res & Dev Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions
WO1989004672A1 (en) * 1987-11-20 1989-06-01 The Upjohn Company Derivatives of lincosaminide antibiotics
JPH02502633A (ja) * 1987-12-19 1990-08-23 ラボラトリウム　フュー　エクスペリメンテル　シルージー、フォーチュングスインスティチュート、ダフォス 抗ウィルス性治療用組成物
DE3828582A1 (de) * 1988-08-23 1990-03-01 Max Planck Gesellschaft Monoklonaler antikoerper zur inhibierung der infektion von zellen durch hiv-viren
EP0408372A1 (en) * 1989-07-13 1991-01-16 Smithkline Beecham Corporation Anti-viral therapy
US5591448A (en) * 1994-11-21 1997-01-07 Tepic; Slobodan Anti-viral therapeutic composition
CN106166313B (zh) * 2016-07-01 2018-09-07 浙江大学 一种艾滋病孕妇血液净化器
CN106075626B (zh) * 2016-07-01 2018-06-26 浙江大学 一种艾滋病血液净化治疗仪

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381295A (en) * 1979-04-26 1983-04-26 Ortho Pharmaceutical Corporation Monoclonal antibody to human helper T cells and methods of preparing same
FR2504010B1 (fr) * 1981-04-15 1985-10-25 Sanofi Sa Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation

Also Published As

Publication number Publication date
FR2570278B1 (fr) 1987-02-13
OA08099A (fr) 1987-03-31
EP0176429B1 (fr) 1990-11-22
ES8608884A1 (es) 1986-09-01
EP0176429A1 (fr) 1986-04-02
JP2783403B2 (ja) 1998-08-06
ATE58478T1 (de) 1990-12-15
DE3583400D1 (de) 1991-08-08
JPH0912462A (ja) 1997-01-14
JPS61143328A (ja) 1986-07-01
FR2570278A1 (fr) 1986-03-21
CA1273304A (fr) 1990-08-28
DE3580639D1 (de) 1991-01-03

Similar Documents

Publication Publication Date Title
DK0791571T3 (da) Benzoylderivater
EA199901031A1 (ru) Производные бензимидазола
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
ES546974A0 (es) Un procedimiento de eliminacion del virus lav.
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
FI874166A0 (fi) Anvaendning av 2',3'-dideoxicytidin -2'-en foer behandling av patienter infekterade med retrovirus.
DK178188D0 (da) Antivirusmiddel
SE8206128D0 (sv) Farmaceutisk komposition for behandling av njurstenar framkallade genom infektion
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
EP0335426A3 (en) Compositions and process for protecting t lymphocytes against the etiological agent of lymphadenopathy and acquired immunodepression syndrom
ES2078380T3 (es) Oligofosfatos de accion antiviral.
ES2060162T3 (es) Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
IT1150612B (it) Procedimento per la preparazione del 1',5,7-tridrossi-4'-metossiflavone-7-rutinoside (diosmina)
ES511814A0 (es) "procedimiento de preparacion del n-(1-propil-2-pirrolidinilmetil)-2-metoxi-5-sulfamoil-benzamida".
ES510762A0 (es) Procedimiento de preparacion de 2-oxo-1-pirrolidinilacetatos de 3,3,5-trimetilciclohexilo".
IT8221552A0 (it) Nuovi composti ad attivita'antineoplastica, procedimetno per la loro preparazione e relative composizioni farmaceutiche.
ATE86107T1 (de) Arginin- und agmatinderivate zur behandlung von protozoen-infektionen.
ES264730Y (es) "juego de composicion, perfeccionado".

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020506